HK1148945A1 - Methods and compositions for oral administration of protein and peptide therapeutic agents - Google Patents
Methods and compositions for oral administration of protein and peptide therapeutic agentsInfo
- Publication number
- HK1148945A1 HK1148945A1 HK11103123.1A HK11103123A HK1148945A1 HK 1148945 A1 HK1148945 A1 HK 1148945A1 HK 11103123 A HK11103123 A HK 11103123A HK 1148945 A1 HK1148945 A1 HK 1148945A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- compositions
- methods
- oral administration
- therapeutic agents
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL188647A IL188647A0 (en) | 2008-01-08 | 2008-01-08 | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
US8029508P | 2008-07-14 | 2008-07-14 | |
PCT/IL2009/000036 WO2009087633A2 (en) | 2008-01-08 | 2009-01-08 | Methods and compositions for oral administration of protein and peptide therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1148945A1 true HK1148945A1 (en) | 2011-09-23 |
Family
ID=40326402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11103123.1A HK1148945A1 (en) | 2008-01-08 | 2011-03-28 | Methods and compositions for oral administration of protein and peptide therapeutic agents |
Country Status (16)
Country | Link |
---|---|
US (3) | US8936786B2 (de) |
EP (2) | EP2231123B1 (de) |
JP (1) | JP5432183B2 (de) |
KR (1) | KR101588066B1 (de) |
AU (2) | AU2009203529B2 (de) |
BR (1) | BRPI0906866A2 (de) |
CA (2) | CA2711554C (de) |
DK (2) | DK2231123T3 (de) |
EA (1) | EA018461B1 (de) |
ES (2) | ES2397061T3 (de) |
HK (1) | HK1148945A1 (de) |
IL (3) | IL188647A0 (de) |
MX (1) | MX2010007462A (de) |
NZ (1) | NZ586374A (de) |
WO (2) | WO2009087633A2 (de) |
ZA (1) | ZA201004480B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL188647A0 (en) * | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
CA2767342C (en) * | 2009-07-09 | 2018-05-01 | Oshadi Drug Administration Ltd. | Matrix carrier compositions, methods and uses |
KR102014512B1 (ko) * | 2011-05-02 | 2019-08-26 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 항-α4β7 항체에 대한 제형 |
EP2809780B1 (de) | 2012-02-01 | 2018-05-02 | Protalix Ltd. | Inhalierbare flüssige formulierungen der dnase i |
WO2014031837A1 (en) * | 2012-08-22 | 2014-02-27 | The Regents Of The University Of California | Compositions and methods for enhancing sialic acid levels in tissue |
EP2919903B1 (de) | 2012-11-14 | 2020-07-22 | W.R. Grace & CO. - CONN. | Zusammensetzungen mit einem biologischen wirkstoff und einem nicht geordneten anorganischen oxid |
CA2899220A1 (en) * | 2013-01-29 | 2014-08-07 | Oshadi Drug Administration Ltd. | Pharmaceutical compositions for oral treatment of diabetes |
ES2502691B1 (es) * | 2013-09-25 | 2015-07-07 | Sani-Red, S.L. | Método de conservación y estabilización de proteínas, aplicable para desarrollos industriales de formulaciones de productos sanitarios, farmacéuticos y cosméticos |
EP3065717A1 (de) | 2013-11-04 | 2016-09-14 | Biopharmx, Inc. | Darreichungsform mit einen wirkstoff und mehreren porösen festkörper-mikroträgern |
US9168211B2 (en) * | 2014-03-28 | 2015-10-27 | Johnson & Johnson Consumer Inc. | Method of making an anhydrous, pigmented composition |
KR102418550B1 (ko) * | 2015-11-03 | 2022-07-06 | 삼성전자주식회사 | 포토 레지스트 패턴 형성 방법 및 이를 이용한 반도체 장치 제조 방법 |
US10660941B2 (en) | 2016-02-19 | 2020-05-26 | Indian Institute Of Technology, Bombay | Orally administrable pharmaceutical preparation containing protein |
EP3456859A1 (de) | 2017-09-13 | 2019-03-20 | Rolex Sa | Schutzbeschichtung für ein komplexes uhrenbauteil |
RU2718554C1 (ru) * | 2017-09-25 | 2020-04-08 | Георгий Георгиевич Чумбуридзе | Термостабильная композиция, обладающая антивирусной и антибактериальной активностью и ее использование |
CA3134550A1 (en) * | 2019-04-11 | 2020-10-15 | R.P. Scherer Technologies, Llc | Formulation for oral delivery of proteins, peptides and small molecules with poor permeability |
MX2022007326A (es) | 2019-12-17 | 2022-09-23 | 9286 3620 Quebec Inc | Sistemas de suministro oral basados en la formacion in situ de coacervados de proteínas polisacáridos. |
JP2023511439A (ja) | 2020-01-28 | 2023-03-17 | ジェネンテック, インコーポレイテッド | がんの治療のためのil15/il15rアルファヘテロ二量体fc融合タンパク質 |
JP2023534810A (ja) | 2020-07-15 | 2023-08-14 | シャバー リサーチ アソシエイツ エルエルシー | 急性痛の処置並びに胸やけの重症度及び/又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物 |
WO2023286049A1 (en) | 2021-07-12 | 2023-01-19 | Zidkiyahu Simenhaus | Protein containing bio-active compositions comprising cellulose microparticle carriers |
US20230399362A1 (en) | 2022-06-13 | 2023-12-14 | B.A.I. Laboratories, Llc | Interleukin-13 binding cyclic oligopeptides and methods of use thereof |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3252859A (en) * | 1962-10-24 | 1966-05-24 | Masti Kure Company Inc | Colloidal silica-oil composition and method of using same |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
ES2027518A6 (es) | 1990-12-18 | 1992-06-01 | Andromaco Lab | Procedimiento para la preparacion de nuevas asociaciones no covalentes polisacarido-proteina con actividad farmacologica. |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5260002A (en) | 1991-12-23 | 1993-11-09 | Vanderbilt University | Method and apparatus for producing uniform polymeric spheres |
US7083572B2 (en) | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
US20040018236A1 (en) * | 1995-05-08 | 2004-01-29 | Robert Gurny | Nanoparticles for oral administration of pharmaceutical agents of low solubility |
ES2093562B1 (es) | 1995-05-26 | 1997-07-01 | Univ Santiago Compostela | Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido. |
US6071535A (en) * | 1996-01-31 | 2000-06-06 | Collaborative Laboratories, Inc. | Lipid vesicles formed with alkylammonium fatty acid salts |
US5874105A (en) | 1996-01-31 | 1999-02-23 | Collaborative Laboratories, Inc. | Lipid vesicles formed with alkylammonium fatty acid salts |
US6322765B1 (en) * | 1996-02-15 | 2001-11-27 | Wacker-Chemie Gmbh | Process for preparing silicon dioxide |
US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US20020039594A1 (en) | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
US6171586B1 (en) * | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
FR2767718B1 (fr) * | 1997-08-28 | 1999-10-22 | Oreal | Emulsion eau-dans-huile comprenant de la silice pyrogenee et un alkylether de polysaccharide |
US6638621B2 (en) | 2000-08-16 | 2003-10-28 | Lyotropic Therapeutics, Inc. | Coated particles, methods of making and using |
ATE246039T1 (de) * | 1997-09-09 | 2003-08-15 | Select Release L C | Beschichtete teilchen, methode zu ihrer herstellung und verwendung |
FR2773804B1 (fr) | 1998-01-19 | 2000-02-18 | Sanofi Sa | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
US6656922B2 (en) * | 1998-05-28 | 2003-12-02 | Mediplex Corporation, Korea | Oral delivery of macromolecules |
BR0009437A (pt) * | 1999-03-31 | 2002-01-15 | Janssen Pharmaceutica Nv | Amido pré-gelatinizado em uma formulação de liberação controlada |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
US7195780B2 (en) | 2002-10-21 | 2007-03-27 | University Of Florida | Nanoparticle delivery system |
DE10001172A1 (de) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templatieren von Feststoffpartikeln mit Polymermultischichten |
JP4631119B2 (ja) | 2000-01-28 | 2011-02-16 | Jsr株式会社 | 疎水化コロイダルシリカの製造方法 |
US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
US6548264B1 (en) * | 2000-05-17 | 2003-04-15 | University Of Florida | Coated nanoparticles |
NZ523017A (en) * | 2000-06-29 | 2004-10-29 | Emisphere Tech Inc | Compounds and compositions for delivering active agents and preparation method thereof |
DE50012404D1 (de) | 2000-08-11 | 2006-05-11 | Lohmann Animal Health Gmbh | W/o Emulsion Adjuvanszuzammensetzungen für Impstoffen |
US20020150621A1 (en) | 2000-10-16 | 2002-10-17 | Kohane Daniel S. | Lipid-protein-sugar particles for drug delivery |
FR2819720B1 (fr) * | 2001-01-22 | 2004-03-12 | Fournier Lab Sa | Nouveaux comprimes de fenofibrate |
US6698247B2 (en) * | 2001-05-04 | 2004-03-02 | Corning Incorporated | Method and feedstock for making silica by flame combustion |
US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
AU2002364701B8 (en) * | 2001-11-20 | 2006-06-22 | Alkermes, Inc. | Compositions for sustained action product delivery |
JP2005513145A (ja) | 2001-12-21 | 2005-05-12 | セラター テクノロジーズ インコーポレイテッド | 改変されたポリマー脂質送達ビヒクル |
US20030235619A1 (en) * | 2001-12-21 | 2003-12-25 | Christine Allen | Polymer-lipid delivery vehicles |
US20030198666A1 (en) * | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
WO2003059288A2 (en) * | 2002-01-09 | 2003-07-24 | Enzrel, Inc. | Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
CA2474283A1 (en) | 2002-02-07 | 2003-08-14 | Yissum Research Development Company Of The Hebrew University In Jerusale M | Amino acid sequences capable of facilitating penetration across a biological barrier |
US7244498B2 (en) | 2002-06-12 | 2007-07-17 | Tda Research, Inc. | Nanoparticles modified with multiple organic acids |
US7090868B2 (en) | 2002-09-13 | 2006-08-15 | University Of Florida | Materials and methods for drug delivery and uptake |
ES2465496T3 (es) * | 2003-01-06 | 2014-06-05 | Emisphere Technologies, Inc. | Terapia de insulina oral nocturna |
US20040242729A1 (en) | 2003-05-30 | 2004-12-02 | 3M Innovative Properties Company | Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
JP2007523050A (ja) | 2003-09-17 | 2007-08-16 | カイアズマ・リミテッド | 生物学的障壁を通した透過を容易にすることのできる組成物 |
KR20060097020A (ko) * | 2003-10-31 | 2006-09-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 약물 전달용 나노입자 |
KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
AU2005329255B2 (en) | 2004-04-15 | 2010-09-30 | Chiasma, Inc. | Compositions capable of facilitating penetration across a biological barrier |
US7288134B2 (en) | 2004-09-10 | 2007-10-30 | International Business Machines Corporation | Dumbbell-like nanoparticles and a process of forming the same |
US7282194B2 (en) | 2004-10-05 | 2007-10-16 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
WO2006044660A2 (en) | 2004-10-14 | 2006-04-27 | Vanderbilt University | Functionalized solid lipid nanoparticles and methods of making and using same |
WO2006062506A1 (en) * | 2004-12-03 | 2006-06-15 | Enzrel, Inc. | Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds |
US7923682B2 (en) * | 2005-08-09 | 2011-04-12 | University Of Sunderland | Fingerprint analysis using mass spectrometry |
ES2761937T3 (es) | 2005-10-24 | 2020-05-21 | Magsense Life Sciences Inc | Método para preparar micropartículas recubiertas con polímero |
WO2007056424A2 (en) * | 2005-11-07 | 2007-05-18 | Penwest Pharmaceuticals, Co. | Controlled-release emulsion compositions |
US20070258889A1 (en) * | 2005-11-09 | 2007-11-08 | Montana State University | Novel nanoparticles and use thereof |
EP1957113A4 (de) | 2005-11-21 | 2011-11-09 | Medivas Llc | Polymerteilchen zur ausgabe von makromolekülen und anwendungsverfahren dafür |
US20070184076A1 (en) | 2006-02-07 | 2007-08-09 | Unger Evan C | Liquid-filled nanodroplets for anti-cancer therapy |
CA2649109A1 (en) * | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
IL188647A0 (en) * | 2008-01-08 | 2008-11-03 | Orina Gribova | Adaptable structured drug and supplements administration system (for oral and/or transdermal applications) |
CA2767342C (en) * | 2009-07-09 | 2018-05-01 | Oshadi Drug Administration Ltd. | Matrix carrier compositions, methods and uses |
-
2008
- 2008-01-08 IL IL188647A patent/IL188647A0/en unknown
-
2009
- 2009-01-08 JP JP2010541885A patent/JP5432183B2/ja not_active Expired - Fee Related
- 2009-01-08 ES ES09700655T patent/ES2397061T3/es active Active
- 2009-01-08 EA EA201070827A patent/EA018461B1/ru not_active IP Right Cessation
- 2009-01-08 CA CA2711554A patent/CA2711554C/en not_active Expired - Fee Related
- 2009-01-08 EP EP09701269A patent/EP2231123B1/de not_active Not-in-force
- 2009-01-08 ES ES09701269T patent/ES2398015T3/es active Active
- 2009-01-08 BR BRPI0906866-0A patent/BRPI0906866A2/pt not_active Application Discontinuation
- 2009-01-08 MX MX2010007462A patent/MX2010007462A/es active IP Right Grant
- 2009-01-08 KR KR1020107016634A patent/KR101588066B1/ko not_active IP Right Cessation
- 2009-01-08 WO PCT/IL2009/000036 patent/WO2009087633A2/en active Application Filing
- 2009-01-08 DK DK09701269.4T patent/DK2231123T3/da active
- 2009-01-08 CA CA2711556A patent/CA2711556A1/en not_active Abandoned
- 2009-01-08 AU AU2009203529A patent/AU2009203529B2/en not_active Ceased
- 2009-01-08 WO PCT/IL2009/000037 patent/WO2009087634A2/en active Application Filing
- 2009-01-08 NZ NZ586374A patent/NZ586374A/en not_active IP Right Cessation
- 2009-01-08 DK DK09700655.5T patent/DK2254590T3/da active
- 2009-01-08 US US12/811,871 patent/US8936786B2/en not_active Expired - Fee Related
- 2009-01-08 EP EP09700655A patent/EP2254590B1/de not_active Not-in-force
- 2009-01-08 AU AU2009203530A patent/AU2009203530B2/en not_active Ceased
- 2009-01-08 US US12/811,859 patent/US20100278922A1/en not_active Abandoned
-
2010
- 2010-06-24 ZA ZA2010/04480A patent/ZA201004480B/en unknown
- 2010-07-06 IL IL206834A patent/IL206834A/en not_active IP Right Cessation
- 2010-07-06 IL IL206835A patent/IL206835A/en not_active IP Right Cessation
-
2011
- 2011-03-28 HK HK11103123.1A patent/HK1148945A1/xx not_active IP Right Cessation
-
2014
- 2014-12-09 US US14/565,416 patent/US9949924B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1148945A1 (en) | Methods and compositions for oral administration of protein and peptide therapeutic agents | |
HK1214153A1 (zh) | 用於口服給予蛋白質的方法和組合物 | |
HK1223558A1 (zh) | 用於口服給予艾塞那肽的方法和組合物 | |
IL276157A (en) | Pharmaceutical preparations and methods for transferring them related to them | |
ZA201007522B (en) | Methods and compositions for oral administration of proteins | |
EP1933862A4 (de) | Verfahren und zusammensetzungen zur oralen verabreichung von proteinen | |
IL211099A0 (en) | Formulation for oral administration of proteins | |
EP2049137A4 (de) | Salicylanilide als verstärker der oralen freisetzung therapeutischer peptide | |
EP2152293A4 (de) | Zusammensetzungen zur proteinabgabe und verfahren zu deren verwendung | |
IL197442A (en) | Therapeutic compositions containing glp-elp fusion proteins and their use in preparing a drug | |
IL202684A0 (en) | Anti-cd20 therapeutic compositions and methods of use thereof | |
HK1142823A1 (en) | Formulations for the oral administration of therapeutic agents and related methods | |
EP1755633A4 (de) | Orale abgabe von pharmazeutischen peptid-zusammensetzungen | |
PL386296A1 (pl) | Sposób otrzymywania preparatów peptydowych do podawania doustnego | |
EP1993523A4 (de) | Zusammensetzungen und verfahren zur behandlung von störungen bei der proteinaggregation | |
IL245352A0 (en) | Methods and preparations for administering proteins orally | |
IL210842A0 (en) | Methods and compositions for oral administration of proteins | |
IL208165A0 (en) | Methods and compositions for oral administration of proteins | |
IL189956A0 (en) | Methods and compositions for oral administration of proteins | |
IL208967A0 (en) | Methods and compositions for oral administration of exenatide | |
IL201676A0 (en) | Oral delivery of proteins and peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190108 |